New CPT Codes for COVID-19 Anti-body Testing

April 17, 2020

Effective for dates of service on or after April 10, 2020, the American Medical Association (AMA) has released specific CPT® codes to report and track COVID-19 antibody testing. The AMA has revised code 86318 (immunoassay for infectious agent antibody[ies], qualitative or semiquantitative, single step method) and established 86328 (immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method; severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] [Coronavirus disease (COVID-19)]) and 86769 (antibody; severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2] [Coronavirus disease (COVID-19)]) to provide increased specificity to report serologic laboratory testing. Codes 86328 and 86769 each have a frequency limit of two per day and may not be billed with each other on the same date of service. All three codes have been determined to be Medi-Cal benefits.

The updated manual pages reflecting this change will be released in a future Medi-Cal Update.